Biogen Inc
Symbool: 0R1B.L
LSE
220.98
USDMarktprijs vandaag
27.5773
Koers/Winst Verhouding
0.4723
Koers/Winst Groei Verhouding
32.12B
MRK Kapitalisatie
- 0.00%
DIV Rendement
Biogen Inc (0R1B-L) Jaarrekeningen
Balans
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 1049.9 | 4892.8 | 3802.5 | ||||||||||||
balance-sheet.row.short-term-investments | 0 | 0 | 1473.5 | 1541.1 | ||||||||||||
balance-sheet.row.net-receivables | 0 | 2100 | 2136.4 | 1961.7 | ||||||||||||
balance-sheet.row.inventory | 0 | 2527.4 | 1344.4 | 1351.5 | ||||||||||||
balance-sheet.row.other-current-assets | 0 | 1182 | 1417.6 | 740.8 | ||||||||||||
balance-sheet.row.total-current-assets | 0 | 6859.3 | 9791.2 | 7856.5 | ||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 3729.7 | 3702.5 | 3791.8 | ||||||||||||
balance-sheet.row.goodwill | 0 | 6219.2 | 5749 | 5761.1 | ||||||||||||
balance-sheet.row.intangible-assets | 0 | 0 | 1850.1 | 2221.3 | ||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 6219.2 | 7599.1 | 7982.4 | ||||||||||||
balance-sheet.row.long-term-investments | 0 | 460.7 | 1957.1 | 2602.2 | ||||||||||||
balance-sheet.row.tax-assets | 0 | 928.6 | 1226.4 | 1415.1 | ||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 8647.3 | 277.8 | 229.3 | ||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 19985.5 | 14762.9 | 16020.8 | ||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.total-assets | 0 | 26844.8 | 24554.1 | 23877.3 | ||||||||||||
balance-sheet.row.account-payables | 0 | 403.3 | 491.5 | 589.2 | ||||||||||||
balance-sheet.row.short-term-debt | 0 | 240.3 | 97.2 | 1088.2 | ||||||||||||
balance-sheet.row.tax-payables | 0 | 257.4 | 259.9 | 174.7 | ||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 6788.2 | 6281 | 6274 | ||||||||||||
Deferred Revenue Non Current | 0 | 400 | 333 | 330.4 | ||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||||||
balance-sheet.row.other-current-liab | 0 | 2533.3 | 2424.2 | 2446.1 | ||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 8611.1 | 7892.9 | 8619.4 | ||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 400 | 333 | 330.4 | ||||||||||||
balance-sheet.row.total-liab | 0 | 12045.4 | 11165.7 | 12917.6 | ||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.common-stock | 0 | 0.1 | 0.1 | 0.1 | ||||||||||||
balance-sheet.row.retained-earnings | 0 | 17627.6 | 16466.5 | 13911.7 | ||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | -153.7 | -164.9 | -106.7 | ||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | -2674.6 | -2903.8 | -2908.9 | ||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 14799.4 | 13397.9 | 10896.2 | ||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 26844.8 | 24554.1 | 23877.3 | ||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | -9.5 | 63.5 | ||||||||||||
balance-sheet.row.total-equity | 0 | 14799.4 | 13388.4 | 10959.7 | ||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | ||||||||||||
Total Investments | 0 | 460.7 | 3430.6 | 4143.3 | ||||||||||||
balance-sheet.row.total-debt | 0 | 7428.5 | 6711.2 | 7692.6 | ||||||||||||
balance-sheet.row.net-debt | 0 | 6378.6 | 3291.9 | 5431.2 |
Kasstroomoverzicht
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 1161.1 | 3046.9 | 1556.1 | ||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 494.8 | 518.7 | 487.3 | ||||||||||||
cash-flows.row.deferred-income-tax | 0 | -305.8 | -168.6 | -426.8 | ||||||||||||
cash-flows.row.stock-based-compensation | 0 | -1063.8 | 264.3 | 250.8 | ||||||||||||
cash-flows.row.change-in-working-capital | 0 | -648.7 | -890.3 | -145.5 | ||||||||||||
cash-flows.row.account-receivables | 0 | 56.7 | -222.4 | 326 | ||||||||||||
cash-flows.row.inventory | 0 | -130.9 | -320.2 | -462.4 | ||||||||||||
cash-flows.row.account-payables | 0 | 0 | 0 | 0 | ||||||||||||
cash-flows.row.other-working-capital | 0 | -574.5 | -347.7 | -9.1 | ||||||||||||
cash-flows.row.other-non-cash-items | 0 | 1909.6 | -1386.7 | 1918 | ||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -7237.5 | -243.2 | -294.9 | ||||||||||||
cash-flows.row.acquisitions-net | 0 | 12.3 | 595 | 28.1 | ||||||||||||
cash-flows.row.purchases-of-investments | 0 | -5140.7 | -3448.5 | -3808.7 | ||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 8288.5 | 4661.3 | 3498.9 | ||||||||||||
cash-flows.row.other-investing-activites | 0 | -11.3 | 24.4 | 12.9 | ||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -4088.7 | 1589 | -563.7 | ||||||||||||
cash-flows.row.debt-repayment | 0 | -187.3 | -1002.2 | -170 | ||||||||||||
cash-flows.row.common-stock-issued | 0 | -44.3 | -1.9 | -0.7 | ||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | -750 | -1800 | ||||||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | ||||||||||||
cash-flows.row.other-financing-activites | 0 | -6 | -5.6 | -115.5 | ||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 137 | -1759.7 | -2086.2 | ||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 35.1 | -55.7 | -59.8 | ||||||||||||
cash-flows.row.net-change-in-cash | 0 | -2369.4 | 1157.9 | 930.2 | ||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 1049.9 | 3419.3 | 2261.4 | ||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 3419.3 | 2261.4 | 1331.2 | ||||||||||||
cash-flows.row.operating-cash-flow | 0 | 1547.2 | 1384.3 | 3639.9 | ||||||||||||
cash-flows.row.capital-expenditure | 0 | -7237.5 | -243.2 | -294.9 | ||||||||||||
cash-flows.row.free-cash-flow | 0 | -5690.3 | 1141.1 | 3345 |
Rij winst-en-verliesrekening
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 9417 | 9433.4 | 10402.4 | ||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 3028.2 | 2797 | 2597 | ||||||||||||
income-statement-row.row.gross-profit | 0 | 6388.8 | 6636.4 | 7805.4 | ||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||
income-statement-row.row.other-expenses | 0 | 0 | 0 | 0 | ||||||||||||
income-statement-row.row.operating-expenses | 0 | 4757.5 | 4362.3 | 4940.2 | ||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 7785.7 | 7159.3 | 7537.2 | ||||||||||||
income-statement-row.row.interest-income | 0 | 276.5 | 89.3 | 11 | ||||||||||||
income-statement-row.row.interest-expense | 0 | 268.6 | 263.7 | 289.9 | ||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -334.5 | 1317.7 | -1120 | ||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||
income-statement-row.row.other-operating-expenses | 0 | 0 | 0 | 0 | ||||||||||||
income-statement-row.row.total-operating-expenses | 0 | -334.5 | 1317.7 | -1120 | ||||||||||||
income-statement-row.row.interest-expense | 0 | 268.6 | 263.7 | 289.9 | ||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 494.8 | 518.7 | 487.3 | ||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | ||||||||||||
income-statement-row.row.operating-income | 0 | 1631.3 | 2274.1 | 2865.2 | ||||||||||||
income-statement-row.row.income-before-tax | 0 | 1296.8 | 3591.8 | 1745.2 | ||||||||||||
income-statement-row.row.income-tax-expense | 0 | 135.3 | 632.8 | 52.5 | ||||||||||||
income-statement-row.row.net-income | 0 | 1161.1 | 3046.9 | 1556.1 |
Vaak gestelde vragen
Wat is Biogen Inc (0R1B.L) totale activa?
Biogen Inc (0R1B.L) totale activa is 26844800000.000.
Wat is de jaarlijkse omzet van de onderneming?
De jaarlijkse omzet is N/A.
Wat is de winstmarge van de onderneming?
De bedrijfswinstmarge is 0.678.
Wat is vrije kasstroom van de onderneming?
De vrije kasstroom is {free_cash_flow}}.
Wat is de nettowinstmarge van de onderneming?
De nettowinstmarge is 0.123.
Wat is de totale omzet van de onderneming?
De totale opbrengst is 0.173.
Wat is Biogen Inc (0R1B.L) nettowinst (netto-inkomen)?
De nettowinst is 1161100000.000.
Wat is de totale schuld van het bedrijf?
De totale schuld is 7428500000.000.
Wat zijn de bedrijfskosten?
De bedrijfsuitgaven zijn 4757500000.000.
Wat is het kasstroomcijfer van het bedrijf?
Enretprise cash is 0.000.